INTRODUCTION: Implantable loop recorder (ILR) insertion has historically been performed in a surgical environment such as the electrophysiology (EP) lab. The newest generation loop recorder (Medtronic Reveal LINQ™, Minneapolis, MN, USA) is injectable with potential for implantation in a non-EP lab setting by advanced practice providers (APPs) facilitating improved workflow and resource utilization. We report the safety and efficacy of injectable ILR placement in the ambulatory care setting by APPs. METHODS: A retrospective review was performed including all patients referred for injectable ILR placement from March 2014 to November 2015. All device placement procedures were performed in an ambulatory care setting using the standard manufacturer deployment kit with sterile technique and local anesthetic following a single dose of intravenous antibiotics. Acute procedural success and complication rates following injectable ILR placement in the ambulatory setting were reviewed. RESULTS: During the study period, 125 injectable ILRs were implanted. Acute procedural success with adequate sensing (R-waves ≥ 0.2 mV) occurred in 100% of patients. There were no acute procedural complications. Subacute complications occurred in two patients (1.6% of implantations), including one possible infection treated with oral antibiotics and one device removal due to pain at the implant site. CONCLUSION: In this retrospective single-center study, implantation of injectable ILR in an ambulatory care setting by APPs following a single dose of intravenous antibiotics and standard manufacturer technique yielded a low complication rate with high acute procedural success. Use of this implantation strategy may improve EP lab workflow while providing a safe and effective technique for device placement.
INTRODUCTION: Implantable loop recorder (ILR) insertion has historically been performed in a surgical environment such as the electrophysiology (EP) lab. The newest generation loop recorder (Medtronic Reveal LINQ™, Minneapolis, MN, USA) is injectable with potential for implantation in a non-EP lab setting by advanced practice providers (APPs) facilitating improved workflow and resource utilization. We report the safety and efficacy of injectable ILR placement in the ambulatory care setting by APPs. METHODS: A retrospective review was performed including all patients referred for injectable ILR placement from March 2014 to November 2015. All device placement procedures were performed in an ambulatory care setting using the standard manufacturer deployment kit with sterile technique and local anesthetic following a single dose of intravenous antibiotics. Acute procedural success and complication rates following injectable ILR placement in the ambulatory setting were reviewed. RESULTS: During the study period, 125 injectable ILRs were implanted. Acute procedural success with adequate sensing (R-waves ≥ 0.2 mV) occurred in 100% of patients. There were no acute procedural complications. Subacute complications occurred in two patients (1.6% of implantations), including one possible infection treated with oral antibiotics and one device removal due to pain at the implant site. CONCLUSION: In this retrospective single-center study, implantation of injectable ILR in an ambulatory care setting by APPs following a single dose of intravenous antibiotics and standard manufacturer technique yielded a low complication rate with high acute procedural success. Use of this implantation strategy may improve EP lab workflow while providing a safe and effective technique for device placement.
Authors: Nikolas Nozica; George C M Siontis; Elena Georgieva Elchinova; Eleni Goulouti; Masahiko Asami; Joanna Bartkowiak; Samuel Baldinger; Helge Servatius; Jens Seiler; Hildegard Tanner; Fabian Noti; Andreas Haeberlin; Mattia Branca; Jonas Lanz; Stefan Stortecky; Thomas Pilgrim; Stephan Windecker; Tobias Reichlin; Fabien Praz; Laurent Roten Journal: Front Cardiovasc Med Date: 2022-05-16
Authors: Prashanthan Sanders; Christopher Piorkowski; Johannes A Kragten; Grahame K Goode; Satish R Raj; Trang Dinh; M Rizwan Sohail; Rishi Anand; Angel Moya-Mitjans; Noreli Franco; Kurt Stromberg; John D Rogers Journal: BMC Cardiovasc Disord Date: 2019-05-31 Impact factor: 2.298
Authors: Thomas Deneke; Pilar Cabanas; Daniel Hofer; Thomas Gaspar; Bertrand Pierre; Giovanni Bisignani; Rajeev Kumar Pathak; Victor Manuel Sanfins; Eimo Martens; Jacques Mansourati; Antonio Berruezo-Sanchez; Marcus Wiemer; Andreas Hain; Thomas Pezawas; Beate Wenzel; Dennis Lau Journal: Heart Rhythm O2 Date: 2022-01-30